Back to Search Start Over

Opsoclonus-Myoclonus-Associated Neuroblastoma With Bone Marrow Metastases: What Would Be the Best Treatment Option?

Authors :
Gizhlaryan M
Aghabekyan T
Arakelyan T
Petrosyan M
Iskanyan S
Tamamyan G
Sargsyan L
Papyan R
Source :
Oncology (Williston Park, N.Y.) [Oncology (Williston Park)] 2021 Oct 22; Vol. 35 (10), pp. 665-667. Date of Electronic Publication: 2021 Oct 22.
Publication Year :
2021

Abstract

A 1.9-year-old girl was presented to the hospital with dancing eye movements, ataxia, and behavioral disorders. The MRI showed a retroperitoneal tumor (transversal size: 3.9 x 2.5 cm, craniocaudal size: 4.6 cm) extending from T12 to L3 vertebral bodies (Figure), which was suspicious for neuroblastoma. Afterwards, biopsy of the lesion and bone marrow was performed. The initial pathological evaluation (CD56+, PHOX2B+, NKX2-, Ki67 50%-55%, NSE+, CD99-) of the tumor and bone marrow confirmed the diagnosis of poorly differentiated, high-risk neuroblastoma.

Details

Language :
English
ISSN :
0890-9091
Volume :
35
Issue :
10
Database :
MEDLINE
Journal :
Oncology (Williston Park, N.Y.)
Publication Type :
Academic Journal
Accession number :
34677924
Full Text :
https://doi.org/10.46883/ONC.2021.3510.0665